Home › Device types › LCD
Enzyme Immunoassay, Gentamicin
FDA product code LCD · Class 2 · Clinical Toxicology
24
Registered devices
67
Adverse events
13
Recalls
37
510(k) clearances
Devices with this code
VITROS — ORTHO-CLINICAL DIAGNOSTICS, INC.Syva® Emit® 2000 Gentamicin Plus Assay — Siemens Healthcare Diagnostics Inc.Synchron — Beckman Coulter, Inc.GENT — RANDOX LABORATORIES LIMITEDGENTC — Microgenics CorporationQMS Gentamycin Immunoassay — Microgenics CorporationARCHITECT — Abbott GmbHDimension Vista® Flex® reagent cartridge GENT — Siemens Healthcare Diagnostics Inc.ARCHITECT — Abbott GmbHAtellica CH Gent — Siemens Healthcare Diagnostics Inc.ADVIA Centaur® GENT — Siemens Healthcare Diagnostics Inc.Alinity — ABBOTT LABORATORIESSyva® Emit® 2000 Gentamicin Plus Calibrators — Siemens Healthcare Diagnostics Inc.ADVIA Centaur® Systems, ACS:180® Systems GENT Calibrator — Siemens Healthcare Diagnostics Inc.Dimension® Flex® reagent cartridge GENT — Siemens Healthcare Diagnostics Inc.QMS Gentamicin Assay — Microgenics CorporationADVIA® Chemistry GENT_2 Gentamicin_2 Reagents — Siemens Healthcare Diagnostics Inc.ADVIA Centaur® Systems Gentamicin Calibrator — Siemens Healthcare Diagnostics Inc.ADVIA Centaur® Gentamicin MCM — Siemens Healthcare Diagnostics Inc.CEDIA Gentamicin II Assay — Microgenics CorporationEmit® 2000 Gentamicin Plus Assay — Siemens Healthcare Diagnostics Inc.CEDIA Gentamicin II — Roche Diagnostics GmbHCEDIA Gentamicin II (GENTC) — Microgenics CorporationARCHITECT — ABBOTT LABORATORIES
Recent recalls
| Date | Firm | Reason |
|---|---|---|
| 2020-04-24 | Abbott Gmbh & Co. KG | Abbott identified that samples tested for ARCHITECT STAT High Sensitive Troponin I and STAT High Sensitivity Troponin I assays (LN 3P25 and LN 2R98) may show in |
| 2018-08-13 | bioMerieux, Inc. | Routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Ge |
| 2018-08-13 | bioMerieux, Inc. | Routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Ge |
| 2018-04-19 | Siemens Healthcare Diagnostics, Inc. | The affected lots may exhibit inaccuracy for Quality Control and patient samples at the low end of the Analytical Measurement Range. The bias is due to the cali |
| 2018-04-19 | Siemens Healthcare Diagnostics, Inc. | The affected lots may exhibit inaccuracy for Quality Control and patient samples at the low end of the Analytical Measurement Range. The bias is due to the cali |
| 2010-11-30 | Siemens Healthcare Diagnostics, Inc. | False elevation of Dimension Vista(R) Gentamicin results for patients and QC when prior reagent aspirated by the reagent probe is any of the following plasma pr |
| 2009-10-07 | Roche Diagnostics Operations, Inc. | A high recovery of the assay may be generated, which would lead to an underdosage of gentamicin being administered to the patient. |
| 2009-10-07 | Roche Diagnostics Operations, Inc. | A high recovery of the assay may be generated, which would lead to an underdosage of gentamicin being administered to the patient. |
| 2009-10-07 | Roche Diagnostics Operations, Inc. | A high recovery of the assay may be generated, which would lead to an underdosage of gentamicin being administered to the patient. |
| 2009-02-19 | Beckman Coulter Inc. | The reagent produces false low test results. Beckman Coulter has confirmed low recovery of values at the low end of the therapeutic range (<1.5 ug/mL, <3.13 um |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsSourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.
